Shineco (SISI) announced that InfiniClone, Shineco’s majority-owned subsidiary in which the Company acquired a 51% equity interest on April 25, 2025, has officially launched its Southeast Asian market expansion strategy as it has reached a strategic distribution agreement with Total World Marketing, TWM, pursuant to which TWM will be responsible for the promotion and sale of InfiniClone’s molecular detection kits and InfiniClone’s Purelix series health products in the Southeast Asian market. Shineco believes that this marks a key step in its globalization strategy to develop robust market positioning in the healthcare products and services sector.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SISI:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue